| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income | 7,510 | 13,241 | 9,676 | 31,031 |
| Net loss before income tax | -68,768 | -36,344 | -52,984 | -62,632 |
| Income tax recovery | -11,649 | -1,617 | -7,363 | -11,525 |
| Net loss | -57,119 | -34,727 | -45,621 | -51,107 |
| Foreign currency translation adjustment | -41 | 4,341 | -2,620 | 841 |
| Comprehensive loss | -57,160 | -30,386 | -48,241 | -50,266 |
| Basic (in shares) | 298,875,174 | 298,508,601 | 297,692,663 | 294,851,945 |
| Basic (usd per share) | -0.19 | -0.12 | -0.15 | -0.17 |
| Diluted (in shares) | 298,875,174 | 298,508,601 | 297,692,663 | 294,851,945 |
| Diluted (usd per share) | -0.19 | -0.12 | -0.15 | -0.17 |
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)